BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37310244)

  • 1. Evaluation of an AI Model to Assess Future Breast Cancer Risk.
    Damiani C; Kalliatakis G; Sreenivas M; Al-Attar M; Rose J; Pudney C; Lane EF; Cuzick J; Montana G; Brentnall AR
    Radiology; 2023 Jun; 307(5):e222679. PubMed ID: 37310244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are better AI algorithms for breast cancer detection also better at predicting risk? A paired case-control study.
    Santeramo R; Damiani C; Wei J; Montana G; Brentnall AR
    Breast Cancer Res; 2024 Feb; 26(1):25. PubMed ID: 38326868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway.
    Larsen M; Olstad CF; Lee CI; Hovda T; Hoff SR; Martiniussen MA; Mikalsen KØ; Lund-Hanssen H; Solli HS; Silberhorn M; Sulheim ÅØ; Auensen S; Nygård JF; Hofvind S
    Radiol Artif Intell; 2024 May; 6(3):e230375. PubMed ID: 38597784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing Breast Cancer Risk by Combining AI for Lesion Detection and Mammographic Texture.
    Lauritzen AD; von Euler-Chelpin MC; Lynge E; Vejborg I; Nielsen M; Karssemeijer N; Lillholm M
    Radiology; 2023 Aug; 308(2):e230227. PubMed ID: 37642571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
    Sprague BL; Chen S; Miglioretti DL; Gard CC; Tice JA; Hubbard RA; Aiello Bowles EJ; Kaufman PA; Kerlikowske K
    JAMA Netw Open; 2023 Feb; 6(2):e230166. PubMed ID: 36808238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of artificial intelligence in 7533 consecutive prevalent screening mammograms from the BreastScreen Australia program.
    Waugh J; Evans J; Miocevic M; Lockie D; Aminzadeh P; Lynch A; Bell RJ
    Eur Radiol; 2024 Jun; 34(6):3947-3957. PubMed ID: 37955669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis.
    Larsen M; Olstad CF; Koch HW; Martiniussen MA; Hoff SR; Lund-Hanssen H; Solli HS; Mikalsen KØ; Auensen S; Nygård J; Lång K; Chen Y; Hofvind S
    Radiology; 2023 Oct; 309(1):e230989. PubMed ID: 37847135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
    Alaeikhanehshir S; Voets MM; van Duijnhoven FH; Lips EH; Groen EJ; van Oirsouw MCJ; Hwang SE; Lo JY; Wesseling J; Mann RM; Teuwen J;
    Cancer Imaging; 2024 Apr; 24(1):48. PubMed ID: 38576031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
    Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
    Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
    Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
    Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Artificial Intelligence for Reducing Unnecessary Recalls at Screening Mammography: A Simulation Study.
    Kim YS; Jang MJ; Lee SH; Kim SY; Ha SM; Kwon BR; Moon WK; Chang JM
    Korean J Radiol; 2022 Dec; 23(12):1241-1250. PubMed ID: 36447412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep Learning Predicts Interval and Screening-detected Cancer from Screening Mammograms: A Case-Case-Control Study in 6369 Women.
    Zhu X; Wolfgruber TK; Leong L; Jensen M; Scott C; Winham S; Sadowski P; Vachon C; Kerlikowske K; Shepherd JA
    Radiology; 2021 Dec; 301(3):550-558. PubMed ID: 34491131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of ductal carcinoma in situ in women undergoing screening mammography.
    Ernster VL; Ballard-Barbash R; Barlow WE; Zheng Y; Weaver DL; Cutter G; Yankaskas BC; Rosenberg R; Carney PA; Kerlikowske K; Taplin SH; Urban N; Geller BM
    J Natl Cancer Inst; 2002 Oct; 94(20):1546-54. PubMed ID: 12381707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Artificial Intelligence Decision Support Using Deep Learning on Breast Cancer Screening Interpretation with Single-View Wide-Angle Digital Breast Tomosynthesis.
    Pinto MC; Rodriguez-Ruiz A; Pedersen K; Hofvind S; Wicklein J; Kappler S; Mann RM; Sechopoulos I
    Radiology; 2021 Sep; 300(3):529-536. PubMed ID: 34227882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
    Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
    Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease.
    Grimm LJ; Miller MM; Thomas SM; Liu Y; Lo JY; Hwang ES; Hyslop T; Ryser MD
    Radiology; 2019 Jul; 292(1):77-83. PubMed ID: 31112087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
    Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
    Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval Cancer Detection Using a Neural Network and Breast Density in Women with Negative Screening Mammograms.
    Wanders AJT; Mees W; Bun PAM; Janssen N; Rodríguez-Ruiz A; Dalmış MU; Karssemeijer N; van Gils CH; Sechopoulos I; Mann RM; van Rooden CJ
    Radiology; 2022 May; 303(2):269-275. PubMed ID: 35133194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Artificial Intelligence-based Mammography Screening Protocol for Breast Cancer: Outcome and Radiologist Workload.
    Lauritzen AD; Rodríguez-Ruiz A; von Euler-Chelpin MC; Lynge E; Vejborg I; Nielsen M; Karssemeijer N; Lillholm M
    Radiology; 2022 Jul; 304(1):41-49. PubMed ID: 35438561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.